glp-1 colorectal cancer mortality study november 2025 Oncology Letters Emerging Evidence Positions GLP-1 Receptor

Combining therapies is not a matter of stacking whatever you can buy online, it is a physician designed protocol built around your goals, your health history, and how your body responds

Peptide Therapy and Cancer: Addressing the Risks, the Evidence, and What Patients Should Know Before Starting Peptide therapy cancer risk evidence is nuanced and most telehealth platforms skip the conversation entirely

Struggling with Your Self-Image

If you have a history of restriction, purging, or misusing medications or other behaviors in the service of losing weight, experts believe that taking a GLP-1 might be especially risky

the semaglutide arm was open-label

Those focused on muscle development should also explore peptides for muscle growth for complementary approaches